Statistical excellence in the pharmaceutical industry
We are now accepting entries for the 2020 awards
The award for statistical excellence in the pharmaceutical industry is made jointly with the Statisticians in the Pharmaceutical Industry (PSI).
The award is for the most influential example of the application of an existing statistical practice, or the implementation of an innovative statistical practice, in this industry.
We are looking for entries that have demonstrated one or more of the following:
- A clear understanding of the needs of researchers and investigators
- An application of an existing statistical practice to a new area that has increased the quality and efficiency of investigations
- A new development in the design of investigations and/or the analysis of data that has led to further insights into the safety, efficacy and value of medicines or devices
- An excellent way to communicate results that is clear and helpful to a wide array of users, showing how statisticians understand the range of user needs
Nominees can be based anywhere in the world and do not need to be a member of PSI or the RSS. The award will be presented at the Annual PSI Conference which will be held in Barcelona, 7-10 June 2020.
The deadline for nominations is 13 April 2020.
The 2019 award was jointly presented to Mike Smith (Pfizer) for ‘Excellence in research around population modelling in drug development’ and Dr Graeme Archer & Jacquie Christie (GSK) for ‘Quantitative Decision-Making for clinical development'.
The 2018 award was jointly presented to Dr Mouna Akacha (Novartis) for “Enhancing drug development using clinically interpretable treatment effect measures (‘estimands‘) that allow for efficient statistical analyses” and Dr. Simon Bate for 'Improving the quality and reliability of animal research through the use of InVivoStat: a statistical software package for animal researchers'.